The title 'Registered Nurse' (also known in the state of Victoria as a 'Division 1 Nurse') is granted to a Nurse who has successfully completed a board approved course in the field of nursing, as outlined by education and registration standards defined by the NMBA.
LINZESSÂ® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBSâC) and chronic idiopathic constipation (CIC). Idiopathic means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children.
The 290 mcg dose is not approved for chronic constipation because studies indicated it was no more effective than the 145 mcg dose. Linzess is approved with a Boxed Warning to alert patients and health care professionals that the drug should not be used in patients 17 years of age and younger.